logoTry Persana

Future Fields - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Future Fields including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Future Fields company logo

We use fruit flies to help scientists change the world.

Future Fields is a fly biotechnology company based in Edmonton, Canada, recognized for its innovative EntoEngine™ platform which uses fruit flies for recombinant protein production.

HeadquartersEdmonton, Canada
Team size41-50
Founded2018

What is Future Fields? - Company Overview & Details

Future Fields is Future Fields is a fly biotechnology company based in Edmonton, Canada, recognized for its innovative EntoEngine™ platform which uses fruit flies for recombinant protein production. Founded in 2018, the company is headquartered in Edmonton, Canada.

Who Founded Future Fields?

Future Fields was founded by Matt Anderson-Baron, Jalene Anderson-Baron.

Who are the Key Executives at Future Fields? - Leadership Team

Future Fields is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Future Fields

Matt Anderson-BaronCEO

Chief Technology Officer (CTO) of Future Fields

Jalene Anderson-BaronCTO

About Matt Anderson-Baron - CEO of Future Fields

Matt Anderson-Baron serves as the Chief Executive Officer of Future Fields, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Future Fields Company Details & Key Information

Where is Future Fields located?

Future Fields is headquartered in Edmonton, Canada.

How many employees does Future Fields have?

Future Fields has 41-50 employees.

When was Future Fields founded?

Future Fields was founded in 2018.

Future Fields Official Website

How much funding has Future Fields raised?

Future Fields has raised $15.1 Million across 7 funding rounds. The most recent funding was completed on 2023-03-22.

Funding Overview

Future Fields has raised a total of $15.1 million in funding to date, with the latest round supporting its biomanufacturing initiatives.

$15.1 Million
Total Funding Raised
7
Funding Rounds
2023-03-22
Latest Round

Future Fields Funding History

Seed Extension
2023-03-22
$11.2 Million

Who are the key investors in Future Fields?

Future Fields is backed by 2 key investors including Bee Partners, Toyota Ventures. These investors focus on Biotechnology, Sustainability, Mobility sectors.

Future Fields Investor Overview

2
Key Investors
4
Focus Areas
2
Notable Investments

Complete List of Future Fields Investors

Bee Partners

Bee Partners is a venture capital firm backing innovators and entrepreneurs.

Investment Focus
Biotechnology
Sustainability
Notable Portfolio Companies
Future Fields

Toyota Ventures

Toyota Ventures focuses on investing in innovative companies that benefit society and align with Toyota's vision.

Investment Focus
Mobility
Sustainable Tech
Notable Portfolio Companies
Future Fields

What sectors do Future Fields investors focus on?

The investors backing Future Fields primarily focus on Biotechnology, Sustainability, Mobility, Sustainable Tech sectors.

Biotechnology
Sustainability
Mobility
Sustainable Tech

Featured Investor: Bee Partners

Bee Partners

Bee Partners is a venture capital firm backing innovators and entrepreneurs.

Notable Investments: Future Fields

What are Future Fields's future plans?

Future Fields Future Fields aims to expand its CDMO services and increase production capacity with new facilities.

Future Fields Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Future Fields face?

Future Fields has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Future Fields

1

Scaling production effectively

2

Competing with traditional biomanufacturing methods

What opportunities does Future Fields have?

Future Fields has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Future Fields

1

Expanding into biopharmaceutical markets

2

Partnerships with biotech firms

Future Fields Strategic Position Summary

Key Focus Areas

Future Fields is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Future Fields?

Future Fields has 2 recent news updates covering key business developments and market activities.

Future Fields News Overview

2
Recent Articles
Active
Media Coverage
2024-11-15
Latest Update

What is Future Fields in the news for?

Future Fields is currently featured in news for Future Fields launched CDMO service on Sep 1st '23. and other significant business developments.

Recent News Articles About Future Fields

Article 1
2024-11-15

Future Fields launched CDMO service on Sep 1st '23.

In September 2023, Future Fields introduced a new CDMO service aimed at enhancing pharmaceutical production capabilities.

healthcarewebwire.com
Read News
Article 2
2024-11-12

Future Fields launches Instar 1.0.

Future Fields has launched Instar 1.0, a new protein manufacturing facility that revolutionizes protein production utilizing its EntoEngine technology.

synbiobeta.com
Read News

Future Fields FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Future Fields including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

Future Fields Questions & Answers - Company Information

Q1

What is Future Fields?

Future Fields is a fly biotechnology company based in Edmonton, Canada, recognized for its innovative EntoEngine™ platform which uses fruit flies for recombinant protein production.

Q2

Who founded Future Fields?

Future Fields was founded by Matt Anderson-Baron, Jalene Anderson-Baron.

Q3

Who is the CEO of Future Fields?

The CEO of Future Fields is Matt Anderson-Baron. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Future Fields raised?

Future Fields has raised a total of $$15.1 Million across 7 funding rounds. The most recent funding was completed on 2023-03-22.

Q5

Who are the investors in Future Fields?

Future Fields's key investors include Bee Partners, Toyota Ventures.

Q6

Where is Future Fields headquartered?

Future Fields is headquartered in Edmonton, Canada.

Q7

When was Future Fields founded?

Future Fields was founded in 2018.

Q8

How many employees does Future Fields have?

Future Fields has 41-50 employees.

Q9

What is Future Fields's official website?

You can visit Future Fields's official website at http://www.futurefields.io.

Q10

What was Future Fields's latest funding round?

Future Fields's latest funding round was a Seed Extension round of $$11.2 Million completed on 2023-03-22.

Q11

Who is founder?

Matt Anderson-Baron

Q12

Who is cto?

Jalene Anderson-Baron

Q13

What does the company do?

Future Fields uses fruit flies to produce recombinant proteins sustainably and cost-effectively.

Q14

How much funding?

$15.1 Million

Q15

Latest funding date?

2023-03-22

Q16

Who are the investors?

Bee Partners Toyota Ventures

Q17

What are the challenges?

Scaling production effectively Competing with traditional biomanufacturing methods

Q18

What are the opportunities?

Expanding into biopharmaceutical markets Partnerships with biotech firms

Q19

Latest news?

In September 2023, Future Fields introduced a new CDMO service aimed at enhancing pharmaceutical production capabilities. Future Fields has launched Instar 1.0, a new protein manufacturing facility that revolutionizes protein production utilizing its EntoEngine technology.

More Information About Future Fields

For additional details about Future Fields, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.